| ISIN | LU0634964992 |
|---|---|
| Valor Number | 13111230 |
| Bloomberg Global ID | |
| Fund Name | MEMNON FUND-Memnon European Fund W USD |
| Fund Provider |
Zadig Gestion Luxembourg
Phone: +352 26 47 6301 Web: www.zadig.lu |
| Fund Provider | Zadig Gestion Luxembourg |
| Representative in Switzerland |
Reyl & Cie S.A. Genève Phone: +41 22 816 80 00 |
| Distributor(s) | CACEIS (Switzerland) SA |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | The objective of this Sub-Fund is to maximise long term capital growth by investing primarily in quoted equity listed on or dealt in Regulated Markets within the EEA, UK and Switzerland which are issued by companies with principal offices in the EEA, UK and Switzerland. To achieve its investment objective, this Sub-Fund will base its investments on fundamental research in the selection of Transferable Securities for long positions. |
| Peculiarities |
| Current Price * | 448.55 USD | 02.12.2025 |
|---|---|---|
| Previous Price * | 449.59 USD | 01.12.2025 |
| 52 Week High * | 449.59 USD | 01.12.2025 |
| 52 Week Low * | 435.52 USD | 21.11.2025 |
| NAV * | 448.55 USD | 02.12.2025 |
| Issue Price * | 448.55 USD | 02.12.2025 |
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 402,511,892 | |
| Unit/Share Assets *** | 827,312 | |
| Trading Information SIX | ||
| YTD Performance | - | - |
|---|---|---|
| YTD Performance (in CHF) | - | - |
| 1 month | +2.99% |
21.11.2025 - 02.12.2025
21.11.2025 02.12.2025 |
| 3 months | - | - |
| 6 months | - | - |
| 1 year | - | - |
| 2 years | - | - |
| 3 years | - | - |
| 5 years | - | - |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| AstraZeneca PLC | 7.17% | |
|---|---|---|
| Societe Generale SA | 5.91% | |
| Continental AG | 5.41% | |
| Merck KGaA | 5.37% | |
| STMicroelectronics NV | 5.16% | |
| Erste Group Bank AG. | 4.90% | |
| ASML Holding NV | 4.55% | |
| Kerry Group PLC Class A | 4.51% | |
| Prysmian SpA | 4.50% | |
| Roche Holding AG | 4.49% | |
| Last data update | 31.08.2025 | |
| TER *** | 1.491% |
|---|---|
| TER date *** | 31.08.2025 |
| Performance Fee *** | 15.00% |
| PTR | |
| Max. Management Fee *** | 1.25% |
| Ongoing Charges *** | |
|
SRRI ***
|
|
| SRRI date *** | 30.06.2024 |